Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study

Inclusion criteria

• Meets the diagnostic criteria for Carotid Atherosclerotic Plaque (CAP);
• Meets the diagnostic criteria for dyslipidemia;
• Meets the TCM syndrome differentiation criteria for Qi Stagnation and Blood Stasis pattern;
• Aged 18-75 years, both sexes eligible;
• Vital signs stable, conscious with normal communication ability;
• Subject voluntarily participates and signs the informed consent form.

Exclusion criteria

• Patients with severe cardiovascular diseases, including acute myocardial infarction, unstable angina, NYHA Class II-IV heart failure, severe arrhythmias, congenital heart disease, or severe valvular heart disease;
• Patients with poorly controlled hypertension (systolic blood pressure ≥180 mmHg or diastolic blood pressure >100 mmHg), severe cerebrovascular diseases, hemorrhagic or hematologic disorders, or malignant tumors;
• Patients with hepatic dysfunction, defined as alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) levels exceeding twice the upper limit of normal, or renal insufficiency, defined as serum creatinine levels exceeding 1.5 times the upper limit of normal;
• Patients with severe psychological disorders, intellectual disabilities, or language barriers;
• Pregnant or lactating women;
• Patients with known hypersensitivity to the investigational drug;
• Patients concurrently participating in other clinical trials.